Metformin Hydrochloride Extended-Release Tablets Recalled for Foreign Tablet Contamination
A-S Medication Solutions is recalling 411 bottles of Metformin Hydrochloride Extended-Release 500mg tablets (Lot #4260340) distributed nationwide due to the presence of foreign tablets or capsules.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving contamination with foreign tablets in prescription medication—a risk-of-harm product. No reported illnesses or injuries are mentioned in the source, meeting the criteria for High severity: a risk-of-harm product where injury has not yet been reported.
Plain-English summary
A-S Medication Solutions is recalling Metformin Hydrochloride Extended-Release 500mg tablets (NDC 50090-1494-3) due to the presence of foreign tablets or capsules in affected bottles.
The recall affects 411 bottles of Lot #4260340 with an expiration date of 12/31/2025. The product was distributed nationwide in the United States.
Patients using this medication should contact their pharmacy or healthcare provider regarding their specific supply. Do not use medication from the affected lot without consulting a healthcare provider first.
The recalled product
- Product
- METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE)
- Brand
- METFORMIN HYDROCHLORIDE
- Manufacturer
- A-S Medication Solutions LLC
- Hazard
- foreign-objects
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 4260340
- Exp.12/31/2025.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METFORMIN HYDROCHLORIDE
- ModerateMetformin Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2025-04-16
- SevereMetformin Hydrochloride Extended-Release Tablets Recalled for NDMA Contamination
FDA (Drugs) · 2022-02-02
- HighMetformin Hydrochloride Tablets Recalled for NDMA Contamination
FDA (Drugs) · 2021-06-30
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27